Edition:
United States

Oncternal Therapeutics Inc (ONCT.PH)

ONCT.PH on Philadelphia Stock Exchange

5.86USD
23 Aug 2019
Change (% chg)

$1.13 (+23.89%)
Prev Close
$4.73
Open
$5.86
Day's High
$5.86
Day's Low
$5.86
Volume
100
Avg. Vol
813
52-wk High
$25.50
52-wk Low
$0.77

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 22.92 33.85
P/E High - Last 5 Yrs. -- 113.98 54.29
P/E Low - Last 5 Yrs. -- 26.40 28.22
Beta 1.84 0.50 0.99
Price to Sales (TTM) -- 6.34 7.90
Price to Book (MRQ) 5.75 3.92 4.38
Price to Tangible Book (MRQ) 3.69 5.67 5.07
Price to Cash Flow (TTM) -- 15.69 23.70
% Owned Institutions 3.49 7.67 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.13 1.67
Dividend Yield - 5 Year Avg -- 0.87 1.37
Dividend 5 Year Growth Rate -- 5.73 6.82
Payout Ratio(TTM) -- 25.45 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 10.04 14.65
Sales (TTM) vs TTM 1 Yr. Ago -- 7.22 8.45
Sales - 5 Yr. Growth Rate -- 10.87 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 60.91 74.10 19.40
EPS (TTM) vs TTM 1 Yr. Ago 34.71 -- --
EPS - 5 Yr. Growth Rate -- 6.01 7.15
Capital Spending - 5 Yr. Growth Rate -- 3.79 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.20 2.52
Current Ratio (MRQ) 12.39 3.43 3.52
LT Debt to Equity (MRQ) 0.00 39.83 12.61
Total Debt to Equity (MRQ) 0.00 51.15 17.64
Interest Coverage (TTM) -- 30.23 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.31 50.25
Gross Margin - 5 Yr. Avg. -- 40.27 51.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 12.42 16.42
Operating Margin (TTM) -- 7.40 -6.97
Operating Margin - 5 Yr. Avg. -- 6.61 11.87
Pre-Tax Margin (TTM) -- 10.26 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- 7.64 15.72
Net Profit Margin (TTM) -- 6.83 -11.11
Net Profit Margin - 5 Yr. Avg. -- 5.01 11.11
Effective Tax Rate (TTM) -- 28.99 20.61
Effective Tax Rate - 5 Yr. Avg. -- 143.87 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,276,842 870,638,159
Net Income/Employee (TTM) -1,460,143 -624,403 101,855,832
Receivable Turnover (TTM) -- 8.57 5.88
Inventory Turnover (TTM) -- 83.06 3.66
Asset Turnover (TTM) 0.00 0.69 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -107.60 7.09 10.25
Return on Assets - 5 Yr. Avg. -81.80 6.25 11.17
Return on Investment (TTM) -134.59 8.86 12.69
Return on Investment - 5 Yr. Avg. -150.03 7.93 14.15
Return on Equity (TTM) -134.59 -1.09 17.13
Return on Equity - 5 Yr. Avg. -150.35 11.26 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 5.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncternal Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -25.08 -27.16 21 50
13 Week -37.47 -39.25 43 61
26 Week -21.10 -30.52 99 42
52 Week -96.09 -96.33 14 44
YTD -8.61 -24.28 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.49%
# of Holders: 57
Total Shares Held: 535,877
3 Mo. Net Change: -2,137
# New Positions: 0
# Closed Positions: 4
# Increased Positions: 1
# Reduced Positions: 7
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.